𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A transcriptional response to Wnt protein in human embryonic carcinoma cells

✍ Scribed by Jennifer Willert; Mirjam Epping; Jonathan R Pollack; Patrick O Brown; Roel Nusse


Book ID
104492633
Publisher
BioMed Central
Year
2002
Tongue
English
Weight
416 KB
Volume
2
Category
Article
ISSN
1471-213X

No coin nor oath required. For personal study only.

✦ Synopsis


Background: Wnt signaling is implicated in many developmental decisions, including stem cell control, as well as in cancer. There are relatively few target genes known of the Wnt pathway.

Results:

We have identified target genes of Wnt signaling using microarray technology and human embryonic carcinoma cells stimulated with active Wnt protein. The ~50 genes upregulated early after Wnt addition include the previously known Wnt targets Cyclin D1, MYC, ID2 and Ξ²TRCP. The newly identified targets, which include MSX1, MSX2, Nucleophosmin, Follistatin, TLE/ Groucho, Ubc4/5E2, CBP/P300, Frizzled and REST/NRSF, have important implications for understanding the roles of Wnts in development and cancer. The protein synthesis inhibitor cycloheximide blocks induction by Wnt, consistent with a requirement for newly synthesized Ξ²catenin protein prior to target gene activation. The promoters of nearly all the target genes we identified have putative TCF binding sites, and we show that the TCF binding site is required for induction of Follistatin. Several of the target genes have a cooperative response to a combination of Wnt and BMP.

Conclusions: Wnt signaling activates genes that promote stem cell fate and inhibit cellular differentiation and regulates a remarkable number of genes involved in its own signaling system.


πŸ“œ SIMILAR VOLUMES


Functional antagonism between activin an
✍ Ester Piek; Mozhgan Afrakhte; Kuber Sampath; E. Joop Van Zoelen; Carl-Henrik Hel πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 237 KB

Activin A and osteogenic protein-1 (OP-1) exerted antagonistic effects on each other's responses on the human Tera-2 embryonal carcinoma cell line. OP-1 dose dependently inhibited activin A-induced activation of p3TP-Lux transcriptional reporter, containing part of the human plasminogen activator in